paroxetine has been researched along with Cardiotoxicity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glumac, S; Japundžić-Žigon, N; Kosić, M; Nešić, Z; Pajović, V; Savić, B; Vasić, M | 1 |
| Jackson, DB; Kim, S; Lahu, G; Lesko, LJ; Soldatos, TG; Trame, MN; Vakilynejad, M | 1 |
| Gu, J; Ji, G; Song, F; Wu, L; Wu, W; Zhu, Y | 1 |
3 other study(ies) available for paroxetine and Cardiotoxicity
| Article | Year |
|---|---|
Paroxetine mitigates cardiac remodelling by doxorubicin and increases survival.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Gene Expression Regulation; Male; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Ventricular Remodeling | 2022 |
A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development.
Topics: Cardiotoxicity; Doxorubicin; Drug Development; Drug-Related Side Effects and Adverse Reactions; Humans; Lapatinib; Paroxetine; Patient-Centered Care; Tamoxifen; Trastuzumab | 2022 |
Paroxetine induced larva zebrafish cardiotoxicity through inflammation response.
Topics: Animals; Cardiotoxicity; Embryo, Nonmammalian; Inflammation; Larva; Paroxetine; T-Box Domain Proteins; Water Pollutants, Chemical; Zebrafish; Zebrafish Proteins | 2023 |